Associations between calcium-phosphate metabolism and coronary artery calcification; a cross sectional study of a middle-aged general population.
High serum calcium-phosphate levels are associated with increased risk of cardiovascular disease (CVD) in patients with chronic kidney disease. Recent studies have demonstrated this relationship also in subjects with normal kidney function. Our aim was to examine whether calcium-phosphate metabolism is associated with the presence and extent of coronary artery calcification (CAC) in asymptomatic and apparently healthy individuals.



Serum samples from 1088 randomly recruited middle-aged men and women without known CVD and diabetes (DM), from the general population, were analysed for total calcium, phosphate, parathyroid hormone (PTH) and 25-hydroxyvitamin D (25(OH)D). CAC was measured by a non-contrast cardiac CT scan and categorised into four groups: 0, 1-99, 100-399, ≥400 Agatston units. The association of calcium-phosphate metabolism with CAC was evaluated by a multiple ordered logistic regression model. All the multiple regression analyses were performed in the entire cohort as well as in men and women separately.



In the study population, 96% of the serum calcium values, 93% of the PTH values, 90% of the phosphate values, and only 64% of the 25(OH)D values were placed within the normal range. In men, the odds of being in a higher CAC category, i.e. having more severe CAC, increased by 30% when serum calcium concentration increased by 0.1 mmol/l (95% CI: 1.04-1.61, p = 0.019), independently of traditional cardiovascular risk factors. In women, no significant association between serum calcium and CAC was identified (OR 0.99, 95% CI: 0.81-1.21, p = 0.91). Neither phosphate, PTH nor 25(OH)D was significantly associated with CAC in men, in women or when performed in the entire cohort.



Serum calcium, even with values within normal range and independent of traditional risk factors, was significantly associated with CAC in asymptomatic and apparently healthy middle-aged men, but not in women.
Department of Cardiology, Odense University Hospital, Sdr. Boulevard 29, DK-5000 Odense C, Denmark; Centre for Individualized Medicine in Arterial Diseases (CIMA), Odense University Hospital, Sdr. Boulevard 29, DK-5000 Odense C, Denmark. Electronic address: mettehjortdal@gmail.com.
Mette Hjortdal
MH
Grønhøj
Department of Nuclear Medicine, Odense University Hospital, Sdr. Boulevard 29, DK-5000 Odense, Denmark; Centre of Health Economics Research, University of Southern Denmark, Campusvej 55, DK-5230 Odense M, Denmark.
Oke
O
Gerke
Department of Cardiology, Odense University Hospital, Sdr. Boulevard 29, DK-5000 Odense C, Denmark.
Hans
H
Mickley
Department of Cardiology, Vejle Hospital, Kabbeltoft 25, DK-7100 Vejle, Denmark.
Flemming Hald
FH
Steffensen
Department of Cardiology, Svendborg Hospital, Valdemarsgade 53, DK-5700 Svendborg, Denmark.
Jess
J
Lambrechtsen
Department of Cardiology, Hospital of South West Denmark, Finsensgade 35, DK-6700 Esbjerg, Denmark; Institute of Regional Health Services Research, University of Southern Denmark, Winsløwparken 19, 3., DK-5000 Odense C, Denmark.
Niels Peter Rønnow
NPR
Sand
Department of Clinical Biochemistry and Pharmacology, Odense University Hospital, Sdr. Boulevard 29, DK-5000 Odense C, Denmark.
Lars Melholt
LM
Rasmussen
Centre for Individualized Medicine in Arterial Diseases (CIMA), Odense University Hospital, Sdr. Boulevard 29, DK-5000 Odense C, Denmark; Cardiology Section, Department of Internal Medicine, Holbæk Hospital, Smedelundsgade 60, DK-4300 Holbæk, Denmark; Cardiovascular Centre of Excellence (CAVAC), University of Southern Denmark, Denmark.
Michael Hecht
MH
Olsen
Department of Cardiology, Odense University Hospital, Sdr. Boulevard 29, DK-5000 Odense C, Denmark; Centre for Individualized Medicine in Arterial Diseases (CIMA), Odense University Hospital, Sdr. Boulevard 29, DK-5000 Odense C, Denmark.
Axel
A
Diederichsen
D015415:Biomarkers / Q000097:blood; D002114:Calcinosis / Q000473:pathology*; D002118:Calcium / Q000097:blood; D002130:Calcium Phosphates / Q000378:metabolism*; D002318:Cardiovascular Diseases / Q000097:blood*; D003331:Coronary Vessels / Q000473:pathology*; D003430:Cross-Sectional Studies; D005260:Female; D064368:Healthy Volunteers; D006801:Humans; D008297:Male; D008875:Middle Aged; D016017:Odds Ratio; D010710:Phosphates / Q000097:blood; D011446:Prospective Studies; D012044:Regression Analysis; D051436:Renal Insufficiency, Chronic / Q000378:metabolism; D012307:Risk Factors
D015415:Biomarkers; D002130:Calcium Phosphates; D010710:Phosphates; C020243:calcium phosphate; D002118:Calcium
Biomarkers; Calcium; Calcium-phosphate metabolism; Computed tomography; Coronary artery calcification; General population; Phosphate